Literature DB >> 15548134

Nucleotide specificity of HIV-1 reverse transcriptases with amino acid substitutions affecting Ala-114.

Clara E Cases-González1, Luis Menéndez-Arias.   

Abstract

Ala-114, together with Asp-113, Tyr-115 and Gln-151, form the pocket that accommodates the 3'-OH of the incoming dNTP in the HIV-1 RT (reverse transcriptase). Four mutant RTs having serine, glycine, threonine or valine instead of Ala-114 were obtained by site-directed mutagenesis. While mutants A114S and A114G retained significant DNA polymerase activity, A114T and A114V showed very low catalytic efficiency in nucleotide incorporation assays, due to their high apparent K(m) values for dNTP. Discrimination between AZTTP (3'-azido-3'-deoxythymidine triphosphate) and dTTP was not significantly affected by mutations A114S and A114G in assays carried out with heteropolymeric template/primers. However, both mutants showed decreased susceptibility to AZTTP when poly(rA)/(dT)16 was used as substrate. Steady-state kinetic analysis of the incorporation of ddNTPs compared with dNTPs showed that substituting glycine for Ala-114 produced a 5-6-fold increase in the RT's ability to discriminate against ddNTPs (including the physiologically relevant metabolites of zalcitabine and didanosine), a result that was confirmed in primer-extension assays. In contrast, A114S and A114V showed wild-type ddNTP/dNTP discrimination efficiencies. Discrimination against ribonucleotides was not affected by mutations at position 114. Misinsertion and mispair extension fidelity assays as well as determinations of G-->A mutation frequencies using a lacZ complementation assay showed that, unlike Tyr-115 or Gln-151 mutants, the fidelity of HIV-1 RT was not largely affected by substitutions of Ala-114. The role of the side-chain of Ala-114 in ddNTP/dNTP discrimination appears to be determined by its participation in van der Waals interactions with the ribose moiety of the incoming nucleotide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15548134      PMCID: PMC1134950          DOI: 10.1042/BJ20041056

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptase.

Authors:  P L Boyer; S G Sarafianos; E Arnold; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

2.  DNA polymerase active site is highly mutable: evolutionary consequences.

Authors:  P H Patel; L A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

3.  A single highly mutable catalytic site amino acid is critical for DNA polymerase fidelity.

Authors:  P H Patel; H Kawate; E Adman; M Ashbach; L A Loeb
Journal:  J Biol Chem       Date:  2000-11-07       Impact factor: 5.157

4.  In vivo mutagenesis by Escherichia coli DNA polymerase I. Ile(709) in motif A functions in base selection.

Authors:  A Shinkai; L A Loeb
Journal:  J Biol Chem       Date:  2001-10-15       Impact factor: 5.157

5.  Multiple amino acid substitutions allow DNA polymerases to synthesize RNA.

Authors:  P H Patel; L A Loeb
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

6.  Crystal structures of open and closed forms of binary and ternary complexes of the large fragment of Thermus aquaticus DNA polymerase I: structural basis for nucleotide incorporation.

Authors:  Y Li; S Korolev; G Waksman
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

7.  Coupling ribose selection to fidelity of DNA synthesis. The role of Tyr-115 of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  C E Cases-Gonzalez; M Gutierrez-Rivas; L Ménendez-Arias
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

8.  Mechanism by which phosphonoformic acid resistance mutations restore 3'-azido-3'-deoxythymidine (AZT) sensitivity to AZT-resistant HIV-1 reverse transcriptase.

Authors:  D Arion; N Sluis-Cremer; M A Parniak
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

9.  Molecular architecture of the mutagenic active site of human immunodeficiency virus type 1 reverse transcriptase: roles of the beta 8-alpha E loop in fidelity, processivity, and substrate interactions.

Authors:  K K Weiss; S J Isaacs; N H Tran; E T Adman; B Kim
Journal:  Biochemistry       Date:  2000-09-05       Impact factor: 3.162

10.  Role of murine leukemia virus reverse transcriptase deoxyribonucleoside triphosphate-binding site in retroviral replication and in vivo fidelity.

Authors:  E K Halvas; E S Svarovskaia; V K Pathak
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

View more
  7 in total

Review 1.  Unlocking the sugar "steric gate" of DNA polymerases.

Authors:  Jessica A Brown; Zucai Suo
Journal:  Biochemistry       Date:  2011-01-26       Impact factor: 3.162

2.  The cost of replication fidelity in human immunodeficiency virus type 1.

Authors:  Victoria Furió; Andrés Moya; Rafael Sanjuán
Journal:  Proc Biol Sci       Date:  2007-01-22       Impact factor: 5.349

3.  The impact of molecular manipulation in residue 114 of human immunodeficiency virus type-1 reverse transcriptase on dNTP substrate binding and viral replication.

Authors:  Sarah K Van Cor-Hosmer; Waaqo Daddacha; Z Kelly; Amy Tsurumi; Edward M Kennedy; Baek Kim
Journal:  Virology       Date:  2011-12-05       Impact factor: 3.616

4.  Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells.

Authors:  Alok Mulky; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

5.  Development of Human Immunodeficiency Virus Type 1 Resistance to 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine Starting with Wild-Type or Nucleoside Reverse Transcriptase Inhibitor-Resistant Strains.

Authors:  Maria E Cilento; Aaron B Reeve; Eleftherios Michailidis; Tatiana V Ilina; Eva Nagy; Hiroaki Mitsuya; Michael A Parniak; Philip R Tedbury; Stefan G Sarafianos
Journal:  Antimicrob Agents Chemother       Date:  2021-09-13       Impact factor: 5.191

6.  Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs).

Authors:  Tracy L Diamond; Winnie Ngo; Min Xu; Shih Lin Goh; Silveria Rodriguez; Ming-Tain Lai; Ernest Asante-Appiah; Jay A Grobler
Journal:  Antimicrob Agents Chemother       Date:  2022-05-12       Impact factor: 5.938

7.  Mutation rates and intrinsic fidelity of retroviral reverse transcriptases.

Authors:  Luis Menéndez-Arias
Journal:  Viruses       Date:  2009-12-04       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.